ACQUIREDStale
Column Group IV GP, LP
Eikon Therapeutics Inc · NASDAQ
+89,200 sh · $1.0M
Filed 8 Sept 2026SEC Form 4view source
Column Group IV GP, LP
Eikon Therapeutics Inc · NASDAQ
+89,200 sh · $1.0M
Polen Capital Management
Eikon Therapeutics Inc · NASDAQ
35,742 sh · $466.4K